Kirsten Gruis, M.D.

Kirsten Gruis, M.D.

Former Chief Medical OfficeratDiaMedica Therapeutics· In proxies 2022–2023

Pay in FY2023-41% from the year before · DiaMedica Therapeutics stock +79.7% the same year

Kirsten Gruis, M.D. was paid $596.1K in FY2023 (Dec), down 41%. DiaMedica Therapeutics stock rose 79.7% that year.

Pay$100 in the stock at the end of FY21 → $76
Pay is from the Summary Compensation Table of each DiaMedica Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. DiaMedica TherapeuticsPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role +186%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?